Home/Filings/4/0001225208-10-016021
4//SEC Filing

DREWS JURGEN 4

Accession 0001225208-10-016021

CIK 0000901219other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 2:53 PM ET

Size

20.5 KB

Accession

0001225208-10-016021

Insider Transaction Report

Form 4
Period: 2010-06-30
DREWS JURGEN
Director
Transactions
  • Sale

    Common Stock

    2010-06-30$23.34/sh5,782$134,97241,593 total
  • Exercise/Conversion

    Non-Employee Director Stock Option - Right to Buy

    2010-06-305,78210,218 total
    Exercise: $2.09Exp: 2019-05-07Common Stock (5,782 underlying)
  • Exercise/Conversion

    Non-Employee Director Stock Option - Right to Buy

    2010-06-3011,1204,880 total
    Exercise: $5.97Exp: 2018-05-08Common Stock (11,120 underlying)
  • Sale

    Common Stock

    2010-06-30$23.18/sh20,432$473,64210,041 total
  • Exercise/Conversion

    Non-Employee Director Stock Option - Right to Buy

    2010-06-3020,7320 total
    Exercise: $10.69Exp: 2014-05-21Common Stock (20,732 underlying)
  • Sale

    Common Stock

    2010-06-30$23.39/sh11,120$260,08230,473 total
  • Exercise/Conversion

    Common Stock

    2010-06-30$5.97/sh+11,120$66,38641,893 total
  • Exercise/Conversion

    Common Stock

    2010-06-30$2.09/sh+5,782$12,08447,675 total
  • Exercise/Conversion

    Common Stock

    2010-06-30$10.69/sh+20,732$221,62530,773 total
  • Sale

    Common Stock

    2010-06-30$23.55/sh300$7,06447,375 total
Footnotes (5)
  • [F1]This transaction was executed in multiple trades at 23.55. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
  • [F2]This transaction was executed in multiple trades at prices ranging from $22.91 to $23.63. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
  • [F3]This transaction was executed in multiple trades at prices ranging from $22.91 to $23.69. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
  • [F4]This transaction was executed in multiple trades at prices ranging from $22.53 to $23.51. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
  • [F5]These options have vested and are fully exercisable.

Documents

1 file

Issuer

HUMAN GENOME SCIENCES INC

CIK 0000901219

Entity typeother

Related Parties

1
  • filerCIK 0001184419

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 2:53 PM ET
Size
20.5 KB